跳至主要内容
临床试验/NCT02525107
NCT02525107Unknown3 期

Omega 3 Fatty Acid Therapy for Prevention of Vaso-occlusive Crisis and Manifestations in Omani Patients With Sickle Cell Disease

Sultan Qaboos University2 个研究点 分布在 1 个国家目标入组 280 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
3 期
入组人数
280
试验地点
2
主要终点
Severity of VOC

研究概览

简要总结

140 SCD patients [70 on Hydroxyurea] will receive Omega-3 capsules whereas another 140 SCD patients [70 on Hydroxyurea] will receive placebo and will be recruited from the Sultan Qaboos University Hospital [SQUH] haematology specialty clinics. Patients will be randomized in a 1:1 ratio to receive placebo or Omega-3 for 52 weeks. The aim is to investigate the therapeutic potential of omega-3 fatty acids in the prevention of vaso-occlusive crisis in Omani patients with sickle cell disease[SCD].

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
13 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Moderate to severe Sickle cell disease patients.
  • Patients already receiving Hydroxyurea[HU] are eligible for the study.
  • Patients able and willing to comply with the procedures in the study protocol.

排除标准

  • Acute episodes (infection, vaso-occlusive crises (VOC), acute chest syndrome (ACS), stroke, priapism, splenic sequestration) in the past one month before enrolment.
  • Previous stroke, and other co-morbid diseases like Essential Hypertension, Cardiomyopathy and Heart failure, Diabetes, Chronic Renal Failure.
  • Patients with a history of adverse reaction to omega-3 fatty acid supplementation.
  • Blood transfusion in the previous 3 months.

结局指标

主要结局

Severity of VOC

时间窗: 52 weeks

Reduction in the average visual analog score for pain with scores ranging from 0\[no pain\] to 10\[worst possible pain\] recorded during VOC episodes compared to the previous 52 weeks

Duration of Hospitalization

时间窗: 52 weeks

Reduction in the number of days in hospital with VOC pain compared to the previous 52 weeks

Frequency of VOC

时间窗: 52 weeks

Reduction of the number of Emergency and Hospital visits for VOC episodes compared to the previous 52 weeks

次要结局

  • Red blood cells membrane fatty acids profile(52 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Salam Alkindi

Professor & Head, Department of Haematology

Sultan Qaboos University

研究点 (2)

Loading locations...

相似试验